Antisense oligonucleotides against VR1

US7662948B2 · kind B2 · utility

Assignee

• Gruenenthal GmbH · DE

Inventors

• Jens Kurreck · Berlin, DE
• Volker Erdmann · Berlin, DE

Key dates

• Filing date: Mar 3, 2003
• Grant date: Feb 16, 2010
• Expiry date: May 18, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/3231
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Antisense oligodeoxynucleotides against VR1, corresponding nucleotide constructs, cells containing said nucleotide constructs, pharmaceutical and diagnostic substances, uses thereof in pain therapy, and methods for diagnosing symptoms related to VR1 and for identifying pain-modulating substances.